Ew stock price forecast models derived from discounted cash

EW stock price forecast models derived from discounted cash flow analysis show fair value in the $93–$98 band, reflecting sustained R&D investments and market expansion opportunities in Asia-Pacific. Edwards Lifesciences doesn't pay any regular dividends currently which essentially means that it has been reinvesting all of its profits into the business. This definitely contributes to the decent earnings growth number that we discussed above. In the United States, the company’s leading SAPIEN 3 Ultra RESILIA platform continues to demonstrate strong performance. Sales growth in Europe was also supported by the continued expansion of the platform. In Japan, Edwards remains dedicated to addressing the significant undertreatment of aortic stenosis among the substantial elderly population. Market sentiment towards EW remains bullish, as its 50-day moving average continues to trend above the 200-day support line. Based on recent earnings beats and forward P/E ratios aligning with sector medians, short-term traders are watching the $94 resistance closely.